<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25926657</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>14</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 71 Proteins 2A and 3D Antagonize the Antiviral Activity of Gamma Interferon via Signaling Attenuation.</ArticleTitle><Pagination><StartPage>7028</StartPage><EndPage>7037</EndPage><MedlinePgn>7028-37</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00205-15</ELocationID><Abstract><AbstractText Label="UNLABELLED">Enterovirus 71 (EV71) infection causes severe mortality involving multiple possible mechanisms, including cytokine storm, brain stem encephalitis, and fulminant pulmonary edema. Gamma interferon (IFN-&#x3b3;) may confer anti-EV71 activity; however, the claim that disease severity is highly correlated to an increase in IFN-&#x3b3; is controversial and would indicate an immune escape initiated by EV71. This study, investigating the role of IFN-&#x3b3; in EV71 infection using a murine model, showed that IFN-&#x3b3; was elevated. Moreover, IFN-&#x3b3; receptor-deficient mice showed higher mortality rates and more severe disease progression with slower viral clearance than wild-type mice. In vitro results showed that IFN-&#x3b3; pretreatment reduced EV71 yield, whereas EV71 infection caused IFN-&#x3b3; resistance with attenuated IFN-&#x3b3; signaling in IFN regulatory factor 1 (IRF1) gene transactivation. To study the immunoediting ability of EV71 proteins in IFN-&#x3b3; signaling, 11 viral proteins were stably expressed in cells without cytotoxicity; however, viral proteins 2A and 3D blocked IFN-&#x3b3;-induced IRF1 transactivation following a loss of signal transducer and activator of transcription 1 (STAT1) nuclear translocation. Viral 3D attenuated IFN-&#x3b3; signaling accompanied by a STAT1 decrease without interfering with IFN-&#x3b3; receptor expression. Restoration of STAT1 or blocking 3D activity was able to rescue IFN-&#x3b3; signaling. Interestingly, viral 2A attenuated IFN-&#x3b3; signaling using another mechanism by reducing the serine phosphorylation of STAT1 following the inactivation of extracellular signal-regulated kinase without affecting STAT1 expression. These results demonstrate the anti-EV71 ability of IFN-&#x3b3; and the immunoediting ability by EV71 2A and 3D, which attenuate IFN-&#x3b3; signaling through different mechanisms.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Immunosurveillance by gamma interferon (IFN-&#x3b3;) may confer anti-enterovirus 71 (anti-EV71) activity; however, the claim that disease severity is highly correlated to an increase in IFN-&#x3b3; is controversial and would indicate an immune escape initiated by EV71. IFN-&#x3b3; receptor-deficient mice showed higher mortality and more severe disease progression, indicating the anti-EV71 property of IFN-&#x3b3;. However, EV71 infection caused cellular insusceptibility in response to IFN-&#x3b3; stimulation. We used an in vitro system with viral protein expression to explore the novel IFN-&#x3b3; inhibitory properties of the EV71 2A and 3D proteins through the different mechanisms. According to this study, targeting either 2A or 3D pharmacologically and/or genetically may sustain a cellular susceptibility in response to IFN-&#x3b3;, particularly for IFN-&#x3b3;-mediated anti-EV71 activity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015, American Society for Microbiology. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li-Chiu</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Su-O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Shih-Ping</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yi-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chun-Keung</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chia-Ling</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Center for Translational Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Po-Chun</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Chia-Yuan</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shun-Hua</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-4585-9279</Identifier><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan shunhua@mail.ncku.edu.tw cflin2014@tmu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chiou-Feng</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, Department of Microbiology and Immunology, College of Medicine, Taipei Medical University, Taipei, Taiwan shunhua@mail.ncku.edu.tw cflin2014@tmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>1</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25926657</ArticleId><ArticleId IdType="pmc">PMC4473548</ArticleId><ArticleId IdType="doi">10.1128/JVI.00205-15</ArticleId><ArticleId IdType="pii">JVI.00205-15</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown BA, Pallansch MA. 1995. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 39:195&#x2013;205. doi:10.1016/0168-1702(95)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung HF, He ML. 2011. The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol 37:313&#x2013;327. doi:10.3109/1040841X.2011.580723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1040841X.2011.580723</ArticleId><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. 2013. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol 87:3335&#x2013;3347. doi:10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, King A, Lea S, Newman J, Stuart D. 1997. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol 71:9743&#x2013;9752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230284</ArticleId><ArticleId IdType="pubmed">9371640</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Li ML, Hung CT, Shih SR. 2009. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog 5:e1000593. doi:10.1371/journal.ppat.1000593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000593</ArticleId><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, Chen CC, Stollar V, Shih SR. 2002. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293:386&#x2013;395. doi:10.1006/viro.2001.1310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1310</ArticleId><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XN, Song ZG, Jiang T, Shi BS, Hu YW, Yuan ZH. 2010. Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection. World J Gastroenterol 16:201&#x2013;209. doi:10.3748/wjg.v16.i2.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v16.i2.201</ArticleId><ArticleId IdType="pmc">PMC2806558</ArticleId><ArticleId IdType="pubmed">20066739</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Chen TC, Fang MY, Yen KJ, Shih SR, Hsu JT, Tseng CP. 2010. Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chemother 65:676&#x2013;683. doi:10.1093/jac/dkp502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkp502</ArticleId><ArticleId IdType="pmc">PMC7110181</ArticleId><ArticleId IdType="pubmed">20089540</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut HJ, De Palma AM, Neyts J. 2012. Combating enterovirus replication: state-of-the-art on antiviral research. Biochem Pharmacol 83:185&#x2013;192. doi:10.1016/j.bcp.2011.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2011.08.016</ArticleId><ArticleId IdType="pubmed">21889497</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91&#x2013;107. doi:10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Liu CC. 2009. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther 7:735&#x2013;742. doi:10.1586/eri.09.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.09.45</ArticleId><ArticleId IdType="pubmed">19681701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YF, Abubakar S. 
2003. 
Enterovirus 71 infection induces apoptosis in Vero cells. Malays J Pathol
25:29&#x2013;35. http://www.mjpath.org.my/past_issue/MJP2003.1/EV71%2003.pdf.</Citation><ArticleIdList><ArticleId IdType="pubmed">16196375</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SC, Lin JY, Lo LY, Li ML, Shih SR. 2004. Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol 10:338&#x2013;349. doi:10.1080/13550280490521032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280490521032</ArticleId><ArticleId IdType="pubmed">15765805</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang CC, Sun MJ, Lei HY, Chen SH, Yu CK, Liu CC, Wang JR, Yeh TM. 2004. Human endothelial cell activation and apoptosis induced by enterovirus 71 infection. J Med Virol 74:597&#x2013;603. doi:10.1002/jmv.20216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20216</ArticleId><ArticleId IdType="pubmed">15484266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TC, Lai YK, Yu CK, Juang JL. 2007. Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling. Cell Microbiol 9:2676&#x2013;2688. doi:10.1111/j.1462-5822.2007.00988.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2007.00988.x</ArticleId><ArticleId IdType="pubmed">17581253</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Weng KF, Stollar V, Li ML. 2008. Viral protein synthesis is required for enterovirus 71 to induce apoptosis in human glioblastoma cells. J Neurovirol 14:53&#x2013;61. doi:10.1080/13550280701798980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280701798980</ArticleId><ArticleId IdType="pubmed">18300075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kung SH, Hsu YY, Liu WT. 
2002. 
Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J Gen Virol
83:1367&#x2013;1376. http://vir.sgmjournals.org/content/83/6/1367.long.</Citation><ArticleIdList><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, Yu CK, Su IJ, Liu CC. 2003. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 188:564&#x2013;570. doi:10.1086/376998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/376998</ArticleId><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Yu CK, Wang JR, Su IJ, Liu CC. 2008. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis 198:1002&#x2013;1006. doi:10.1086/591462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591462</ArticleId><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Su LY, Wu JM, Yu CK, Wang JR, Liu CC. 2007. Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity. Clin Microbiol Infect 13:677&#x2013;682. doi:10.1111/j.1469-0691.2007.01729.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2007.01729.x</ArticleId><ArticleId IdType="pubmed">17441979</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Foo DG, Trasti SL, Tan EL, Alonso S. 2011. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J Virol 85:3067&#x2013;3076. doi:10.1128/JVI.01779-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01779-10</ArticleId><ArticleId IdType="pmc">PMC3067852</ArticleId><ArticleId IdType="pubmed">21228224</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Tong J, Liu H, Liu Y, Su Z, Wang S, Shi Y, Zheng D, Sandoghchian S, Geng J, Xu H. 2012. Increased frequency of Th17 cells in the peripheral blood of children infected with enterovirus 71. J Med Virol 84:763&#x2013;767. doi:10.1002/jmv.23254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23254</ArticleId><ArticleId IdType="pubmed">22431024</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Liu CC. 2012. Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clin Dev Immunol 2012:876241. doi:10.1155/2012/876241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/876241</ArticleId><ArticleId IdType="pmc">PMC3432373</ArticleId><ArticleId IdType="pubmed">22956971</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmgaard L. 2004. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 24:439&#x2013;454. doi:10.1089/1079990041689665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/1079990041689665</ArticleId><ArticleId IdType="pubmed">15320958</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ML, Lee YP, Wang YF, Lei HY, Liu CC, Wang SM, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2005. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 86:3263&#x2013;3269. doi:10.1099/vir.0.81195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, He Y, Chen Y, Kung HF, He ML. 2011. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir Ther 16:51&#x2013;58. doi:10.3851/IMP1720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP1720</ArticleId><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CW, Wu CF, Hsiao NW, Chang CY, Li SW, Wan L, Lin YJ, Lin WY. 2008. Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71. Int J Antimicrob Agents 32:355&#x2013;359. doi:10.1016/j.ijantimicag.2008.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2008.04.018</ArticleId><ArticleId IdType="pmc">PMC7126984</ArticleId><ArticleId IdType="pubmed">18701259</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Wang HC, Shih SR, Teng IF, Tseng CP, Hsu JT. 2011. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J Infect Dis 203:1784&#x2013;1790. doi:10.1093/infdis/jir174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir174</ArticleId><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Liu X, Ma Y, Sun Z, Yang Y, Jin Q, He B, Wang J. 2010. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 84:8051&#x2013;8061. doi:10.1128/JVI.02491-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Sun Z, Liu X, Jin Q, He B, Wang J. 2011. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol 85:8811&#x2013;8818. doi:10.1128/JVI.00447-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00447-11</ArticleId><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. 2013. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol 87:1690&#x2013;1698. doi:10.1128/JVI.01855-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01855-12</ArticleId><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YP, Wang YF, Wang JR, Huang SW, Yu CK. 2012. Enterovirus 71 blocks selectively type I interferon production through the 3C viral protein in mice. J Med Virol 84:1779&#x2013;1789. doi:10.1002/jmv.23377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23377</ArticleId><ArticleId IdType="pubmed">22997081</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, Jin Q, Zhao Z. 2013. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog 9:e1003231. doi:10.1371/journal.ppat.1003231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. 2012. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol 86:3767&#x2013;3776. doi:10.1128/JVI.06687-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163&#x2013;189. doi:10.1189/jlb.0603252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0603252</ArticleId><ArticleId IdType="pubmed">14525967</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenborn JR, Wilson CB. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96:41&#x2013;101. doi:10.1016/S0065-2776(07)96002-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-2776(07)96002-2</ArticleId><ArticleId IdType="pubmed">17981204</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine EA, Partidos CD, Santangelo JD, Osorio JE. 2013. Adaptation of enterovirus 71 to adult interferon deficient mice. PLoS One 8:e59501. doi:10.1371/journal.pone.0059501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0059501</ArticleId><ArticleId IdType="pmc">PMC3602422</ArticleId><ArticleId IdType="pubmed">23527208</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zhao N, Su NL, Sun JL, Lv TG, Chen ZB. 2012. Association of interleukin 10 and interferon gamma gene polymorphisms with enterovirus 71 encephalitis in patients with hand, foot and mouth disease. Scand J Infect Dis 44:465&#x2013;469. doi:10.3109/00365548.2011.649490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2011.649490</ArticleId><ArticleId IdType="pubmed">22263663</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Lee YP, Hung YT, Lin CH, Chuang JI, Lei HY, Su IJ, Yu CK. 2011. Exogenous interleukin-6, interleukin-13, and interferon-gamma provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice. Respir Res 12:147. doi:10.1186/1465-9921-12-147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-12-147</ArticleId><ArticleId IdType="pmc">PMC3223501</ArticleId><ArticleId IdType="pubmed">22054060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Chang KC, Kao CM, Chang SP, Tung YY, Chen SH. 2009. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J Virol 83:6477&#x2013;6483. doi:10.1128/JVI.00434-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00434-09</ArticleId><ArticleId IdType="pmc">PMC2698549</ArticleId><ArticleId IdType="pubmed">19386699</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed U.S. National Academies Press, Washington, DC.</Citation></Reference><Reference><Citation>Shen FH, Tsai CC, Wang LC, Chang KC, Tung YY, Su IJ, Chen SH. 2013. Enterovirus 71 infection increases expression of interferon-gamma-inducible protein 10 which protects mice by reducing viral burden in multiple tissues. J Gen Virol 94:1019&#x2013;1027. doi:10.1099/vir.0.046383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.046383-0</ArticleId><ArticleId IdType="pubmed">23288420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung YH, Huang SW, Kuo PH, Kiang D, Ho MS, Liu CC, Yu CK, Su IJ, Wang JR. 2010. Introduction of a strong temperature-sensitive phenotype into enterovirus 71 by altering an amino acid of virus 3D polymerase. Virology 396:1&#x2013;9. doi:10.1016/j.virol.2009.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.10.017</ArticleId><ArticleId IdType="pubmed">19906393</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SH, Garber DA, Schaffer PA, Knipe DM, Coen DM. 2000. Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation. Virology 278:207&#x2013;216. doi:10.1006/viro.2000.0643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0643</ArticleId><ArticleId IdType="pubmed">11112495</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai CC, Kai JI, Huang WC, Wang CY, Wang Y, Chen CL, Fang YT, Lin YS, Anderson R, Chen SH, Tsao CW, Lin CF. 2009. Glycogen synthase kinase-3beta facilitates IFN-gamma-induced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2. J Immunol 183:856&#x2013;864. doi:10.4049/jimmunol.0804033.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0804033</ArticleId><ArticleId IdType="pubmed">19542364</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng PC, Huang WC, Chen CL, Sheu BS, Shan YS, Tsai CC, Wang CY, Chen SO, Hsieh CY, Lin CF. 2012. Regulation of SHP2 by PTEN/AKT/GSK-3beta signaling facilitates IFN-gamma resistance in hyperproliferating gastric cancer. Immunobiology 217:926&#x2013;934. doi:10.1016/j.imbio.2012.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2012.01.001</ArticleId><ArticleId IdType="pubmed">22325465</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742&#x2013;1745. doi:10.1126/science.8456301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8456301</ArticleId><ArticleId IdType="pubmed">8456301</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubblefield Park SR, Widness M, Levine AD, Patterson CE. 2011. T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue. J Virol 85:3664&#x2013;3676. doi:10.1128/JVI.01496-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01496-10</ArticleId><ArticleId IdType="pmc">PMC3067849</ArticleId><ArticleId IdType="pubmed">21270150</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdeinick-Kerr R, Govindarajan D, Griffin DE. 2009. Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling. J Virol 83:3429&#x2013;3435. doi:10.1128/JVI.02381-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02381-08</ArticleId><ArticleId IdType="pmc">PMC2663278</ArticleId><ArticleId IdType="pubmed">19176616</ArticleId></ArticleIdList></Reference><Reference><Citation>Platanias LC. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375&#x2013;386. doi:10.1038/nri1604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1604</ArticleId><ArticleId IdType="pubmed">15864272</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccia EM, Marziali G, Stellacci E, Perrotti E, Ilari R, Orsatti R, Battistini A. 1995. Cells resistant to interferon-beta respond to interferon-gamma via the Stat1-IRF-1 pathway. Virology 211:113&#x2013;122. doi:10.1006/viro.1995.1384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1995.1384</ArticleId><ArticleId IdType="pubmed">7645205</ArticleId></ArticleIdList></Reference><Reference><Citation>Song MM, Shuai K. 1998. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J Biol Chem 273:35056&#x2013;35062. doi:10.1074/jbc.273.52.35056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.52.35056</ArticleId><ArticleId IdType="pubmed">9857039</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura A, Naka T, Kubo M. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7:454&#x2013;465. doi:10.1038/nri2093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2093</ArticleId><ArticleId IdType="pubmed">17525754</ArticleId></ArticleIdList></Reference><Reference><Citation>You M, Yu DH, Feng GS. 1999. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 19:2416&#x2013;2424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC84034</ArticleId><ArticleId IdType="pubmed">10022928</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu TR, Hong YK, Wang XD, Ling MY, Dragoi AM, Chung AS, Campbell AG, Han ZY, Feng GS, Chin YE. 2002. SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei. J Biol Chem 277:47572&#x2013;47580. doi:10.1074/jbc.M207536200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207536200</ArticleId><ArticleId IdType="pubmed">12270932</ArticleId></ArticleIdList></Reference><Reference><Citation>Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1&#x2013;47. doi:10.1099/vir.0.83391-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83391-0</ArticleId><ArticleId IdType="pubmed">18089727</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CH, Li HC, Jiang JG, Hsu CF, Wang YJ, Lai MJ, Juang YL, Lo SY. 2010. Enterovirus type 71 2A protease functions as a transcriptional activator in yeast. J Biomed Sci 17:65. doi:10.1186/1423-0127-17-65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-17-65</ArticleId><ArticleId IdType="pmc">PMC2923119</ArticleId><ArticleId IdType="pubmed">20682079</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang M, Gong J, Luo L, Zhou J, Xiang X, Huang W, Huang Q, Luo X, Olbrot M, Peng Y, Chen C, Luo Z. 2008. Characterization of Ser338 phosphorylation for Raf-1 activation. J Biol Chem 283:31429&#x2013;31437. doi:10.1074/jbc.M802855200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M802855200</ArticleId><ArticleId IdType="pmc">PMC2581588</ArticleId><ArticleId IdType="pubmed">18775988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, King AJ, Diaz HB, Marshall MS. 2000. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Curr Biol 10:281&#x2013;284. doi:10.1016/S0960-9822(00)00359-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(00)00359-6</ArticleId><ArticleId IdType="pubmed">10712905</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang M, Waelde CA, Xiang X, Rana A, Wen R, Luo Z. 2001. Microtubule integrity regulates Pak leading to Ras-independent activation of Raf-1. Insights into mechanisms of Raf-1 activation. J Biol Chem 276:25157&#x2013;25165. doi:10.1074/jbc.M100152200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M100152200</ArticleId><ArticleId IdType="pubmed">11274179</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang M, Hayne C, Luo Z. 2002. Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1. J Biol Chem 277:4395&#x2013;4405. doi:10.1074/jbc.M110000200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110000200</ArticleId><ArticleId IdType="pubmed">11733498</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Weng L, Zhang N, Arita M, Li R, Chen L, Toyoda T. 2011. Biochemical characterization of enterovirus 71 3D RNA polymerase. Biochim Biophys Acta 1809:211&#x2013;219. doi:10.1016/j.bbagrm.2011.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2011.01.001</ArticleId><ArticleId IdType="pubmed">21220056</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Wang Y, Shan C, Chen C, Xu P, Song M, Zhou H, Yang C, Xu W, Shi PY, Zhang B, Lou Z. 2012. Enterovirus 71 VPg uridylation uses a two-molecular mechanism of 3D polymerase. J Virol 86:13662&#x2013;13671. doi:10.1128/JVI.01712-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01712-12</ArticleId><ArticleId IdType="pmc">PMC3503026</ArticleId><ArticleId IdType="pubmed">23055549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehtonen A, Matikainen S, Julkunen I. 1997. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J Immunol 159:794&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">9218597</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>